Metabolic Integration & Fed-Fasted States

Metabolism is not a collection of isolated pathways but an integrated, hormonally-orchestrated system where each organ plays a defined role and fuels are prioritised according to availability and need. This topic ties together glycolysis, gluconeogenesis, glycogen, lipolysis, ketogenesis and protein turnover into one coherent picture — exactly the kind of "join-the-dots" reasoning NEET PG loves to test.

Why integration matters

The body must maintain blood glucose within a narrow range (≈70–110 mg/dL fasting) because the brain and red blood cells are obligate glucose users under most conditions. At the same time it must store surplus energy after meals and mobilise reserves between them. This balance is achieved by inter-organ cooperation and by two master hormones — insulin (the anabolic, "fed" hormone) and glucagon (the catabolic, "fasting" hormone) — with adrenaline, cortisol and growth hormone acting as counter-regulatory backups.

High-yield: The insulin:glucagon ratio (not the absolute level of either) determines whether the liver is in a storage (high ratio, fed) or an export (low ratio, fasting) mode.

Organ-specific metabolism

Each tissue has a "metabolic personality" defined by which enzymes and transporters it expresses.

Organ	Preferred fuel	Key exported product	Diagnostic enzyme/feature
Liver	Variable (glucose, fatty acids, amino acids, alcohol)	Glucose, ketone bodies, VLDL, urea	Glucokinase (high Km, not feedback-inhibited); glucose-6-phosphatase present
Skeletal muscle	Fatty acids (rest), glucose/glycogen (exercise)	Lactate, alanine	Hexokinase (low Km); lacks glucose-6-phosphatase → cannot release free glucose
Cardiac muscle	Fatty acids, ketone bodies, lactate	—	Highly aerobic; lots of mitochondria
Brain	Glucose (ketones in starvation)	—	Cannot use fatty acids (don't cross BBB)
Adipose tissue	Glucose, fatty acids	Free fatty acids, glycerol	Hormone-sensitive lipase; LPL on capillary endothelium
RBC	Glucose (anaerobic glycolysis only)	Lactate	No mitochondria → obligate glycolysis; produces 2,3-BPG
Renal cortex	Fatty acids; performs gluconeogenesis	Glucose (in prolonged fasting)	Second gluconeogenic organ after liver

High-yield: RBC and the renal medulla are obligate glucose users that produce lactate because they lack mitochondria. The brain is NOT an obligate glucose user in starvation — it adapts to ketones.

High-yield: Liver has glucose-6-phosphatase; muscle does NOT. This single fact explains why muscle glycogen cannot raise blood glucose and why muscle keeps its glucose-6-phosphate for its own use.

The liver as metabolic hub

The liver sits between the gut (receiving nutrients via the portal vein) and the rest of the body. It buffers blood glucose, synthesises and exports ketone bodies and VLDL, makes urea from amino-acid nitrogen, and is the only organ with the full enzymatic outfit for both glycogenolysis-with-glucose-release and gluconeogenesis. Glucokinase (hexokinase IV) has a high Km (~10 mM), is not inhibited by its product glucose-6-phosphate, and is induced by insulin — making the liver a glucose "overflow" sensor that traps glucose only when it is abundant.

The fed (absorptive) state

Lasts roughly 2–4 hours after a meal. Blood glucose rises → insulin secreted → insulin:glucagon ratio high.

Hormonal driver: Insulin → promotes glycogenesis, lipogenesis, protein synthesis; inhibits gluconeogenesis, glycogenolysis, lipolysis, ketogenesis.

Stepwise summary of the fed state:

Glucose ↑ → Insulin ↑ → GLUT4 to muscle/fat membrane → glucose uptake ↑ → glycogen synthesis (liver + muscle) ↑ → excess carbon → fatty-acid synthesis (liver) → VLDL export → triacylglycerol storage in adipose

Key fed-state events by organ:

• Liver: glucokinase traps glucose; glycogen synthase (dephosphorylated, active) builds glycogen; acetyl-CoA carboxylase active → de novo lipogenesis; malonyl-CoA inhibits CPT-1 so fatty acids are NOT oxidised.
• Muscle: GLUT4-mediated glucose uptake; glycogen synthesis; amino-acid uptake and protein synthesis (also driven by insulin).
• Adipose: GLUT4 uptake; lipoprotein lipase (LPL) (insulin-induced) hydrolyses chylomicron/VLDL triacylglycerol so fatty acids enter adipocytes; re-esterification using glycerol-3-phosphate from glycolysis.

High-yield: Malonyl-CoA is the molecular switch — high in the fed state it blocks CPT-1, preventing fatty acids from entering mitochondria for oxidation. Fatty-acid synthesis and oxidation thus cannot run simultaneously.

High-yield: Adipocytes cannot phosphorylate glycerol (lack glycerol kinase). The glycerol-3-phosphate needed for triacylglycerol synthesis comes from glycolysis (DHAP). So fat storage depends on glucose availability.

The fasting state (post-absorptive, ~4–16 h)

Blood glucose falls → insulin falls, glucagon rises → insulin:glucagon ratio low.

Goal: maintain blood glucose for the brain and RBC.

Fuel sources, in order they dominate:

1. Liver glycogenolysis — first responder; hepatic glycogen sustains glucose for ~12–18 h, then is exhausted.
2. Gluconeogenesis — becomes the dominant glucose source after the first several hours; substrates are lactate (Cori cycle), glycerol (from lipolysis), and glucogenic amino acids (chiefly alanine).
3. Lipolysis — adipose hormone-sensitive lipase (now active, dephosphorylated state reversed: it is activated by glucagon/adrenaline via PKA phosphorylation) releases free fatty acids → oxidised by muscle, heart, liver.
4. Ketogenesis — liver converts surplus acetyl-CoA into acetoacetate and β-hydroxybutyrate for export.

High-yield: Hormone-sensitive lipase is activated by phosphorylation (glucagon/adrenaline, PKA) and inhibited by insulin — the mirror image of glycogen synthase regulation.

Two inter-organ cycles to memorise:

Cycle	Carbon carrier	From → To	Purpose
Cori cycle	Lactate / glucose	Muscle (lactate) → Liver (glucose)	Recycles lactate from anaerobic glycolysis into glucose; "exports" the gluconeogenic ATP cost to the liver
Glucose–alanine cycle	Alanine / glucose	Muscle (alanine) → Liver (glucose + urea)	Transports amino nitrogen safely to liver while supplying gluconeogenic carbon

High-yield: Both cycles return glucose to muscle, but the Cori cycle carries no nitrogen, whereas the glucose–alanine cycle simultaneously disposes of amino-acid nitrogen (alanine is the major gluconeogenic amino acid delivered to the liver).

Starvation (prolonged fasting, days to weeks)

Once hepatic glycogen is gone (~24 h), the body shifts decisively to fat as the primary fuel and undertakes brain ketone adaptation to spare protein.

Phases:

• Early starvation (1–3 days): Gluconeogenesis from amino acids is high; muscle protein breakdown peaks; nitrogen loss is maximal. Brain still mostly on glucose.
• Prolonged/adapted starvation (after ~1–2 weeks): The brain derives ~60–75% of its energy from ketone bodies, dramatically reducing its glucose demand. This spares muscle protein → urinary nitrogen excretion falls (clinically seen as decreased urea, increased ammonia to buffer ketoacid load).

High-yield: The single most important adaptation of prolonged starvation is the brain switching to ketone bodies, which reduces the need for gluconeogenesis from muscle protein and thereby prolongs survival. Death in starvation typically follows when fat stores are exhausted and protein catabolism resumes (~loss of ~½ body protein).

High-yield: RBC and renal medulla can NEVER use ketones (no mitochondria) — they remain glucose-dependent throughout starvation, so some gluconeogenesis always continues. The renal cortex itself becomes a major gluconeogenic organ in prolonged starvation.

Ketone-body essentials:

• Synthesised in hepatic mitochondria from acetyl-CoA; rate-limiting enzyme HMG-CoA synthase (mitochondrial).
• Three bodies: acetoacetate, β-hydroxybutyrate (quantitatively dominant in severe ketosis), and acetone (volatile, breath odour, not metabolised).
• Liver makes ketones but cannot use them — it lacks thiophorase (succinyl-CoA:acetoacetate CoA transferase / SCOT).

High-yield: β-hydroxybutyrate : acetoacetate ratio rises in severe ketoacidosis (high NADH/NAD⁺). Standard nitroprusside (Rothera) dipstick detects acetoacetate, NOT β-hydroxybutyrate — so the test can paradoxically underestimate ketosis early in DKA and appear to worsen as the patient improves and β-hydroxybutyrate reconverts to acetoacetate.

AMPK — the cellular energy sensor

AMP-activated protein kinase (AMPK) is activated when AMP:ATP ratio rises (low energy), e.g. during exercise or fasting. Once activated it switches on catabolic, ATP-generating pathways and switches off anabolic, ATP-consuming ones.

AMPK actions (think "low fuel → burn, don't build"):

• ↑ Fatty-acid oxidation (phosphorylates and inhibits acetyl-CoA carboxylase → malonyl-CoA falls → CPT-1 disinhibited).
• ↑ Glucose uptake (GLUT4 translocation in muscle, insulin-independent — basis of exercise-induced glucose uptake).
• ↑ Mitochondrial biogenesis.
• ↓ Fatty-acid, cholesterol and protein (mTOR) synthesis; ↓ glycogen synthesis.

High-yield: Metformin activates AMPK (and inhibits hepatic gluconeogenesis / complex I), explaining its glucose-lowering action without stimulating insulin. AICAR is the classic experimental AMPK activator. Adiponectin and leptin also signal partly via AMPK.

High-yield: Exercise increases muscle glucose uptake independently of insulin via AMPK-driven GLUT4 translocation — this is why exercise helps glycaemic control even in insulin resistance.

Exercise metabolism

Fuel selection depends on intensity and duration:

Phase / intensity	Dominant fuel	Pathway
First few seconds	ATP + creatine phosphate	Phosphagen system
Short, intense (sprint)	Muscle glycogen → lactate	Anaerobic glycolysis (Cori cycle feeds liver)
Moderate, sustained	Blood glucose + muscle glycogen	Aerobic glycolysis
Prolonged endurance	Free fatty acids (β-oxidation)	Aerobic; glucose spared

During endurance exercise, adrenaline drives glycogenolysis and lipolysis, AMPK rises, and the muscle progressively shifts toward fatty-acid oxidation, sparing the limited carbohydrate stores — the physiological basis of "carb loading" and the "wall/bonk" when glycogen is depleted.

Fuel hierarchy and reserves

High-yield: Order of fuel utilisation in fasting: liver glycogen → gluconeogenesis (lactate, glycerol, amino acids) → fatty acids/ketone bodies (prolonged). Muscle glycogen is reserved for the muscle's own use.

Approximate fuel reserves in a 70 kg adult (high-yield comparative magnitudes):

• Triacylglycerol (adipose): by far the largest store (~weeks of energy).
• Protein (muscle): large but functional — not a true "store"; sacrificing it costs function.
• Glycogen (liver + muscle): smallest — lasts roughly a day.
• Free glucose in blood: trivial (minutes).

Diagnosis & laboratory correlation

This is a conceptual topic, but NEET PG frames it through clinical/biochemical scenarios:

• Respiratory quotient (RQ): carbohydrate oxidation RQ = 1.0; fat ≈ 0.7; protein ≈ 0.8; mixed diet ≈ 0.85. A fasting/starving person shows RQ approaching 0.7, reflecting fat oxidation.
• Ketone measurement: serum β-hydroxybutyrate is the preferred quantitative test in DKA (urine dipstick detects acetoacetate/acetone only).
• Blood lactate: elevated in conditions overloading the Cori cycle (shock, vigorous exercise, metformin-associated lactic acidosis at toxic levels).
• C-peptide: distinguishes endogenous insulin (high) from exogenous insulin administration (low) in hypoglycaemia work-up.

Pathophysiology of dysregulation

• Type 1 diabetes / uncontrolled diabetes: functional insulin deficiency mimics an exaggerated fasting state even when fed → unrestrained lipolysis and hepatic ketogenesis → diabetic ketoacidosis (DKA). The low insulin:glucagon ratio drives the whole cascade.
• Alcoholic/starvation ketoacidosis: depleted glycogen + high NADH from ethanol metabolism → gluconeogenesis impaired, fatty-acid oxidation/ketogenesis favoured.
• Reye syndrome: mitochondrial dysfunction with impaired β-oxidation and ureagenesis (classically aspirin in a child with viral illness) → hypoglycaemia + hyperammonaemia.

Key differentials / commonly confused concepts

Confusion	Resolution
Glucokinase vs hexokinase	Glucokinase: liver/β-cell, high Km, not product-inhibited, insulin-induced. Hexokinase: ubiquitous, low Km, inhibited by G6P
Cori cycle vs glucose–alanine cycle	Cori = lactate, no nitrogen; alanine = carries nitrogen to liver
HMG-CoA synthase: cytosolic vs mitochondrial	Cytosolic → cholesterol synthesis; mitochondrial → ketogenesis
LPL vs hormone-sensitive lipase	LPL: capillary endothelium, insulin-induced, clears blood TAG. HSL: intracellular adipocyte, glucagon/adrenaline-activated, mobilises stored TAG
Why liver can't use ketones	Lacks thiophorase (SCOT)

Recently asked / exam angle

• "Enzyme deficient in liver that prevents it from using ketone bodies?" → Thiophorase (SCOT/CoA transferase).
• "Which tissue is an obligate glucose user even in prolonged starvation?" → RBC / renal medulla (no mitochondria).
• "Major fuel of brain after 3 weeks of starvation?" → Ketone bodies (β-hydroxybutyrate).
• "Metformin acts by activating which enzyme?" → AMPK (plus complex-I/gluconeogenesis inhibition).
• "Switch that blocks fatty-acid oxidation in the fed state?" → Malonyl-CoA inhibiting CPT-1.
• "Most abundant ketone body in severe DKA?" → β-hydroxybutyrate, and dipstick may underread it.
• "Cycle that transports amino nitrogen from muscle to liver?" → Glucose–alanine cycle.
• "RQ of a starving individual?" → ~0.7.
• "Why can't adipocytes store fat without glucose?" → no glycerol kinase; need DHAP-derived glycerol-3-phosphate from glycolysis.
• Image/graph-based: insulin:glucagon ratio curves across fed → fasting → starvation; identify the phase.

A classic integration MCQ describes a person fasting for X hours/days and asks for the dominant fuel or glucose source — anchor your answer to the fuel hierarchy timeline above.

Mnemonics & anchors

• "Liver Likes to Give, Muscle is Greedy" — liver has glucose-6-phosphatase and gives glucose to blood; muscle keeps its glucose-6-phosphate.
• HSL = Hungry State Lipase — hormone-sensitive lipase works when you're hungry (fasting), activated by glucagon/adrenaline.
• "Malonyl Muffles CPT-1" — high malonyl-CoA (fed) blocks fatty-acid entry into mitochondria.
• Ketone bodies = "A-B-A" — Acetoacetate, Beta-hydroxybutyrate, Acetone.
• Glucogenic-only amino acids that are NOT ketogenic — most amino acids; purely ketogenic = Leucine and Lysine ("the only Letters").

Rapid revision

1. Insulin:glucagon ratio — high = fed/anabolic; low = fasting/catabolic.
2. Liver has glucose-6-phosphatase; muscle does not — only liver (and kidney) release free glucose.
3. RBC and renal medulla are obligate glucose users (no mitochondria) → produce lactate, never use ketones.
4. Glucokinase: high Km, not product-inhibited, insulin-induced — liver's glucose-overflow sensor.
5. Cori cycle = lactate (no N); glucose–alanine cycle = carries nitrogen to liver.
6. Hormone-sensitive lipase activated by glucagon/adrenaline (PKA phosphorylation), inhibited by insulin.
7. Malonyl-CoA inhibits CPT-1 — the fed-state switch blocking fatty-acid oxidation.
8. Ketogenesis in liver mitochondria; rate-limiting = mitochondrial HMG-CoA synthase; liver can't use ketones (no thiophorase).
9. β-hydroxybutyrate predominates in severe ketoacidosis; urine dipstick detects acetoacetate, underreads βHB.
10. In prolonged starvation the brain runs on ketones, sparing muscle protein and prolonging survival.
11. AMPK = low-energy sensor (high AMP:ATP) → burns fuel, blocks synthesis; metformin activates AMPK; exercise raises muscle glucose uptake via AMPK (insulin-independent).
12. RQ ≈ 1.0 (carbs), 0.7 (fat), 0.8 (protein) — a fasting person trends toward 0.7; fat is the largest body fuel reserve, glycogen the smallest.